EVLO - Evelo Biosciences announces CEO succession plan
- Evelo Biosciences ( NASDAQ: EVLO ) announced the succession plan for Simba Gill, to transition from his roles as CEO and President to the role of Chair of the Board and return to Flagship Pioneering to help launch, grow, and guide bioplatform companies.
- The company board has retained Spencer Stuart, a leading executive search firm, to initiate a comprehensive search to identify Dr. Gill's successor.
- Dr. Gill will continue to serve as CEO and President until his successor joins Evelo, at which time he will become Chair of the Board.
For further details see:
Evelo Biosciences announces CEO succession plan